Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis of Adagrasib (MRTX849), a Covalent KRASG12C Inhibitor Drug for the Treatment of Cancer
Cheng‐yi Chen, Zhichao Lu, Thomas Scattolin, et al.
Organic Letters (2023) Vol. 25, Iss. 6, pp. 944-949
Open Access | Times Cited: 18

Showing 18 citing articles:

The current landscape of using direct inhibitors to target KRASG12C-mutated NSCLC
Firas Batrash, Mahmoud Kutmah, Jun Zhang
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Design, synthesis and biological evaluation of pyrrolopyrimidine urea derivatives as novel KRASG12C inhibitors for the treatment of cancer
Yanguo Shang, M. Pang, Shengnan Fu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117391-117391
Closed Access | Times Cited: 1
Second-Generation Atroposelective Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
Jie Xu, Ngiap‐Kie Lim, Jacob C. Timmerman, et al.
Organic Letters (2023) Vol. 25, Iss. 19, pp. 3417-3422
Closed Access | Times Cited: 15
Design, Synthesis and Biological Evaluation of Pyrrolopyrimidine Urea Derivatives as Novel Krasg12c Inhibitors for the Treatment of Cancer
Yongfeng Shang, Shengnan Fu, M. Pang, et al.
(2025)
Closed Access
Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011–2023
Maria Novella Romanelli, Laura Braconi, Alessio Gabellini, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 68-68
Open Access | Times Cited: 12
Development of a Streamlined Manufacturing Process for the Highly Substituted Quinazoline Core Present in KRAS G12C Inhibitor Divarasib
Johannes A. Burkhard, Sebastian Herold, Christian Leitner, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 1, pp. 102-111
Closed Access | Times Cited: 4
One-pot synthesis of 4-pyrimidone-2-thioether through base/acid-mediated condensation of S-alkylisothiourea and β-ketoester
Zhichao Lu, Tsung-Yun Wong, Yonghong Gan, et al.
RSC Advances (2024) Vol. 14, Iss. 8, pp. 5435-5439
Open Access | Times Cited: 2
Manufacturing Process for 6-Bromo-N,N-bis(4-methoxybenzyl)-4-methyl-5-(trifluoromethyl)pyridin-2-amine, a Key Intermediate in the Synthesis of KRAS G12C Inhibitor Divarasib
Jeff Shen, Nicholas A. White, Qingping Tian, et al.
Organic Process Research & Development (2023) Vol. 28, Iss. 1, pp. 92-101
Closed Access | Times Cited: 6
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 12, pp. 1422-1433
Open Access | Times Cited: 5
Process Development and Manufacture of the Core Starting Material of Adagrasib (MRTX849)
Thomas Scattolin, Dinesh J. Paymode, David R. Snead, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 2, pp. 609-618
Closed Access | Times Cited: 1
Stereochemical Editing via Coupled Epimerization and Optical Resolution to Sustainably Manufacture a Key Adagrasib Building Block
David R. Snead, Sahar Roshandel, Cheng‐yi Chen
Organic Process Research & Development (2023) Vol. 27, Iss. 12, pp. 2393-2399
Closed Access | Times Cited: 2
Adagrasib’s Second-Generation Synthesis: Transitioning from Route Scouting to Optimization
Zhichao Lu, Chengsheng Chen, Dinesh J. Paymode, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 8, pp. 3128-3142
Open Access
Fit-for-Purpose Synthesis of a KRASG12C Covalent Inhibitor, via a Diastereoselective Hayashi Arylation
Carmela Molinaro, Nicholas Wong, Nicholas A. White, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 8, pp. 3313-3325
Closed Access
Zirconium Hydride Catalysis Initiated by Tetrabutylammonium Fluoride
Athenea N. Aloiau, Briana M. Bobek, Kelly E. Pearson, et al.
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 16, pp. 11525-11536
Closed Access
Covalency in PROTACs: Mechanisms and applications
Thomas Geiger, Radosław P. Nowak
Annual reports in medicinal chemistry (2024), pp. 39-61
Closed Access
N-Boc-α-diazo glutarimide as efficient reagent for assembling N-heterocycle-glutarimide diads via Rh(II)-catalyzed N–H insertion reaction
Grigory Kantin, Pavel Golubev, Alexander Sapegin, et al.
Beilstein Journal of Organic Chemistry (2023) Vol. 19, pp. 1841-1848
Open Access | Times Cited: 1
Copper-catalyzed nitration of electron-deficient BN-naphthalene
Xiangdong Fang
Chemical Communications (2023) Vol. 59, Iss. 84, pp. 12581-12584
Closed Access
N-Boc-α-Diazo Glutarimide as Efficient Reagent for Assembling N-Heterocycle-Glutarimide Diads via Rh(II)-Catalyzed N-H Insertion Reaction
Grigory Kantin, Pavel Golubev, Alexander Sapegin, et al.
(2023)
Open Access
Page 1

Scroll to top